Zobrazeno 21 - 30
of 268
pro vyhledávání: '"Pozniak, Anton"'
Autor:
Gurjar R; Department of Pharmacology & Therapeutics, University of Liverpool, Liverpool, UK., Dickinson L; Department of Pharmacology & Therapeutics, University of Liverpool, Liverpool, UK. laurad@liverpool.ac.uk., Carr D; Department of Pharmacology & Therapeutics, University of Liverpool, Liverpool, UK., Stöhr W; MRC Clinical Trials Unit at UCL, London, UK., Bonora S; Unit of Infectious Diseases, University of Turin, Turin, Italy., Owen A; Department of Pharmacology & Therapeutics, University of Liverpool, Liverpool, UK., D'Avolio A; Unit of Infectious Diseases, University of Turin, Turin, Italy., Cursley A; MRC Clinical Trials Unit at UCL, London, UK., De Castro N; Infectious Diseases Department, AP-HP Hôpital Saint-Louis, Paris, France., Fätkenheuer G; Unit of Internal Medicine, University Köln, Köln, Germany., Vandekerckhove L; HIV Translational Research Unit, Ghent University and Ghent University Hospital, Ghent, Belgium., Di Perri G; Unit of Infectious Diseases, University of Turin, Turin, Italy., Pozniak A; Chelsea and Westminster NHS Trust, London, UK., Schwimmer C; University of Bordeaux, INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France., Raffi F; Department of Infectious Diseases, Centre Hospitalier Universitaire de Nantes, and CIC 1413, INSERM, Nantes, France., Boffito M; Chelsea and Westminster NHS Trust, London, UK.; Imperial College, London, UK.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2023 Jan; Vol. 23 (1), pp. 14-20. Date of Electronic Publication: 2022 Oct 20.
Autor:
Girometti N; Chelsea and Westminster Hospital, NHS Foundation Trust, London, UK., Ogoina D; Infectious Diseases Unit, Department of Internal Medicine, Niger Delta University/Niger Delta University Teaching Hospital, Bayelsa, Nigeria., Tan DHS; Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada., Pozniak A; Chelsea and Westminster Hospital, NHS Foundation Trust, London, UK.; London School of Hygiene and Tropical Medicine, London, UK., Klein MB; Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Publikováno v:
Journal of the International AIDS Society [J Int AIDS Soc] 2022 Dec; Vol. 25 (12), pp. e26043.
Autor:
Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel and University of Basel, Basel, Switzerland.; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Marra F; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.; Department of Pharmacy, National Health Service Greater Glasgow and Clyde, Glasgow, UK., Boyle A; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.; Department of Pharmacy, National Health Service Greater Glasgow and Clyde, Glasgow, UK., Gibbons S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Flexner C; Divisions of Clinical Pharmacology and Infectious Diseases, School of Medicine and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Pozniak A; Chelsea and Westminster Hospital National Health Service Foundation Trust, London, UK.; London School of Hygiene and Tropical Medicine, London, UK., Boffito M; Chelsea and Westminster Hospital National Health Service Foundation Trust, London, UK., Waters L; Mortimer Market Centre, Central and North West London, National Health Service Foundation Trust, London, UK., Burger D; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.; Global DDI Solutions, Utrecht, The Netherlands., Back DJ; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Khoo S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Dec; Vol. 112 (6), pp. 1191-1200. Date of Electronic Publication: 2022 Jun 07.
Autor:
Waters L; Central and North West London NHS Foundation Trust, Winston A; Imperial College London and Imperial College Healthcare NHS Trust, London, Reeves I; Homerton Hospital NHS Trust, London, Boffito M; Chelsea and Westminster Hospital NHS Foundation Trust, London, Churchill D; University Hospitals Sussex NHS Foundation Trust, Cromarty B; UK Community Advisory Board and Yorkshire Mesmac, Dunn D; University College London, Fink D; University College London, Fidler S; Imperial College London and Imperial College Healthcare NHS Trust, London, Foster C; Imperial College Healthcare NHS Trust, London, Fox J; Guys and St Thomas’ NHS Foundation Trust and Kings College London, Gupta R; University of Cambridge, Hilton A; UK Community Advisory Board and HiVitality, Khoo S; University of Liverpool, Leen C; NHS Lothian, Mackie N; Imperial College Healthcare NHS Trust, London, Naous N; Chelsea and Westminster Hospital NHS Foundation Trust, London, Ogbonmwan D; University Hospital North Durham, Durham, Orkin C; Queen Mary University of London, Panton L; Western General Hospital, Edinburgh, Post F; King's College Hospital NHS Foundation Trust, London, Pozniak A; Chelsea and Westminster Hospital NHS Foundation Trust, London, Sabin C; University College London, Walsh J; Imperial College Healthcare NHS Trust, London
Publikováno v:
HIV medicine [HIV Med] 2022 Dec; Vol. 23 Suppl 5, pp. 3-115.
Autor:
Venter F; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Sokhela S; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Calmy A; Division of Infectious Diseases, HIV-AIDS Unit, Geneva University Hospitals, Geneva, Switzerland., Siedner MJ; Harvard Medical School, Boston, Massachusetts, USA., Khoo S; University of Liverpool, Liverpool., Clayden P; I-Base, London, UK., Mkhondwane L; Treatment Action Campaign, Johannesburg, South Africa., Bosch B; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Chandiwana N; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Hill A; University of Liverpool, Liverpool., Marconi VC; Division of Infectious Diseases and Department of Global Health, Emory University School of Medicine and Rollins School of Public Health, Atlanta, Georgia, USA., Boffito M; Chelsea and Westminster Hospital, Imperial College, London, UK., Sekwese K; AfroCAB, Lusaka, Zambia., Ali M; Rollins School of Public Health and School of Medicine, Emory University, Atlanta, Georgia, USA., Delaporte E; TransVIHMI, University of Montpellier, Montpellier, France., Pozniak A; Department of Genitourinary Medicine and HIV, Chelsea and Westminster Hospital, London, UK., Mashabane N; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Lalla-Edwards S; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Carman M; Department of Philosophy, Faculty of Humanities, University of the Witwatersrand, Johannesburg, South Africa., Collins S; I-Base, London, UK.
Publikováno v:
AIDS (London, England) [AIDS] 2022 Nov 01; Vol. 36 (13), pp. 1900-1901.
Autor:
Isbell M; Consultant, New York, New York, USA mtisbell@aol.com., Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Rondebosch, South Africa., Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil., Kates J; Henry J Kaiser Family Foundation, Washington, District of Columbia, USA., Kamarulzaman A; University of Malaya, Kuala Lumpur, Malaysia.; Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Lewin SR; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity Melbourne, University of Melbourne, Melbourne, Florida, Australia.; The Peter Doherty Institute for Infection and Immunity, Royal Melbourne Hospital, Melbourne, Florida, Australia., Ngure K; School of Public Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya., Phanuphak N; Institute of HIV Research and Innovation, Bangkok, Thailand., Pozniak A; Department of HIV Medicine, Chelsea & Westminster Hospital NHS Foundation Trust, London, UK.; Department Clinical Research, London School of Hygiene & Tropical Medicine, London, UK., Grimsrud A; HIV Programmes & Advocacy, International AIDS Society, Cape Town, South Africa.
Publikováno v:
BMJ global health [BMJ Glob Health] 2022 Nov; Vol. 7 (11).
Autor:
Saumoy M; Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute, Hospitalet de Llobregat, Spain., Sánchez-Quesada JL; Biochemistry Department, Biomedical Research Institute IIB Sant Pau, Barcelona, Spain., Assoumou L; INSERM, Sorbonne Université, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France., Gatell JM; Faculty of Medicine, University of Barcelona, Barcelona, Spain.; ViiV Healthcare, Barcelona, Spain., González-Cordón A; Infectious Diseases Service, Hospital Clinic/IDIBAPS, Barcelona, Spain., Guaraldi G; University of Modena and Reggio Emilia, Modena, Italy., Domingo P; Infectious Diseases, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Biomèdica del HSCSP, Barcelona, Spain., Giacomelli A; University of Milan, Ospedale Luigi Sacco, Milan, Italy., Connault J; Hotel-Dieu, CHU de Nantes, Nantes, France., Katlama C; Hôpital Pitié-Salpêtrière, Paris, France., Masiá M; Hospital General Universitario de Elche, Elche, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Ordónez-Llanos J; Biochemistry Department, Biomedical Research Institute IIB Sant Pau, Barcelona, Spain.; Foundation for Biochemistry and Molecular Pathology, Barcelona, Spain., Pozniak A; Chelsea & Westminster Hospital NHS Foundation Trust, London, UK.; London School of Hygiene and Tropical Medicine, London, UK., Martínez E; Infectious Diseases Service, Hospital Clinic/IDIBAPS, Barcelona, Spain., Podzamczer D; Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute, Hospitalet de Llobregat, Spain.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Jun 29; Vol. 77 (7), pp. 1980-1988.
Autor:
Papp KA; Probity Medical Research Inc., Waterloo, ON, Canada. kapapp@probitymedical.com.; K Papp Clinical Research, Waterloo, ON, Canada. kapapp@probitymedical.com., Beecker J; Probity Medical Research Inc., Waterloo, ON, Canada.; University of Ottawa, Ottawa, ON, Canada.; Division of Dermatology, The Ottawa Hospital, Ottawa, ON, Canada.; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Cooper C; University of Ottawa, Ottawa, ON, Canada.; Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital and Regional Hepatitis Program, Ottawa, ON, Canada., Kirchhof MG; University of Ottawa, Ottawa, ON, Canada.; Division of Dermatology, The Ottawa Hospital, Ottawa, ON, Canada., Pozniak AL; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Rockstroh JK; Department of Medicine, University of Bonn, Bonn, Germany., Dutz JP; Skin Care Center, Vancouver, BC, Canada.; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Gooderham MJ; Probity Medical Research Inc., Waterloo, ON, Canada.; SKiN Centre for Dermatology, Peterborough, ON, Canada., Gniadecki R; Division of Dermatology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada., Hong CH; Probity Medical Research Inc., Waterloo, ON, Canada.; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.; Dr. Chih-Ho Hong Medical Inc., Surrey, BC, Canada., Lynde CW; Probity Medical Research Inc., Waterloo, ON, Canada.; Lynde Institute for Dermatology, Markham, ON, Canada., Maari C; Innovaderm Research Inc, Montreal, QC, Canada., Poulin Y; Centre de Recherche Dermatologique du Québec Métropolitain, Quebec, QC, Canada., Vender RB; Dermatrials Research Inc., Hamilton, ON, Canada.; Department of Medicine, McMaster University, Hamilton, ON, Canada., Walmsley SL; Toronto General Hospital Research Institute, Toronto, ON, Canada.; University of Toronto, Toronto, ON, Canada.; Department of Medicine, University Health Network, Toronto, ON, Canada.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2022 May; Vol. 12 (5), pp. 1073-1089. Date of Electronic Publication: 2022 Apr 21.
Autor:
Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel and University of Basel, Basel, Switzerland, and Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom (C.M.)., Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (D.R.K.)., Marra F; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, and Department of Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom (F.M., A.B.)., Boyle A; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, and Department of Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom (F.M., A.B.)., Gibbons S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom (S.G., D.Back, S.K.)., Flexner C; Divisions of Clinical Pharmacology and Infectious Diseases, School of Medicine, and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland (C.F.)., Pozniak A; Chelsea and Westminster Hospital NHS Foundation Trust and London School of Hygiene and Tropical Medicine, London, United Kingdom (A.P.)., Boffito M; Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom (M.B.)., Waters L; Mortimer Market Centre, Central and North West London, NHS Foundation Trust, London, United Kingdom (L.W.)., Burger D; Department of Pharmacy, Radboud University Medical Center, Nijmegen, and Global DDI Solutions, Utrecht, the Netherlands (D.Burger)., Back D; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom (S.G., D.Back, S.K.)., Khoo S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom (S.G., D.Back, S.K.).
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2022 May; Vol. 175 (5), pp. 744-746. Date of Electronic Publication: 2022 Mar 01.
Autor:
Waters L; Department of HIV and Sexual Health, Central and North West London NHS Trust, London, WC1E 6JB, UK. Electronic address: lwaters@nhs.net., Marra F; Department of Clinical Pharmacology, University of Liverpool, Liverpool, UK., Pozniak A; Department of Infection, London School of Hygiene & Tropical Medicine, London, UK., Cockburn J; Department of Cardiology, Brighton and Sussex University Hospital, Brighton, UK., Boffito M; Department of HIV and Sexual Health, Chelsea and Westminster NHS Trust, London, UK.
Publikováno v:
Lancet (London, England) [Lancet] 2022 Apr 16; Vol. 399 (10334), pp. 1464-1465. Date of Electronic Publication: 2022 Mar 22.